Request Demo
Recent blog posts
Latest Hotspot
8 min read
Duodenal adenocarcinoma Indication Strategy Report 2026: EGFR, Trials and Deals
23 July 2026
2026 Duodenal adenocarcinoma strategy: epidemiology, EGFR biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Ampullary carcinoma Indication Strategy Report 2026: HER2, Trials and Deals
23 July 2026
2026 Ampullary carcinoma strategy: epidemiology, HER2 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
Esophageal adenocarcinoma Indication Strategy Report 2026: HER2, Trials and Deals
23 July 2026
2026 Esophageal adenocarcinoma strategy: epidemiology, HER2 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Acinar cell carcinoma of pancreas Indication Strategy Report 2026: BRAF, Trials and Deals
23 July 2026
2026 Acinar cell carcinoma of pancreas strategy: epidemiology, BRAF biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
NCT07597902 Nirmatrelvir/Ritonavir Post Acute COVID 19 Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
23 July 2026
NCT07597902 clinical trial report covering Nirmatrelvir/Ritonavir, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261844 BGM-0504 Diabetes Mellitus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
23 July 2026
CTR20261844 clinical trial report covering BGM-0504, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07594678 Minoxidil Chemotherapy-Induced Alopecia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
23 July 2026
NCT07594678 clinical trial report covering Minoxidil, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07595042 Rifapentine Tuberculosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
23 July 2026
NCT07595042 clinical trial report covering Rifapentine, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07597070 Comirnaty-COVID-19 mRNA vaccine metastatic non-small cell lung cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
23 July 2026
NCT07597070 clinical trial report covering Comirnaty-COVID-19 mRNA vaccine, Phase 2, endpoints, sponsor, geography, readout timing and development white space
Latest Hotspot
8 min read
NCT07595393 Rocuronium Bromide Reversal of Neuromuscular Blockade Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
23 July 2026
NCT07595393 clinical trial report covering Rocuronium Bromide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07595874 Botensilimab Advanced Colorectal Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
23 July 2026
NCT07595874 clinical trial report covering Botensilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261937 TollB-001 Scleroderma, Diffuse Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
23 July 2026
CTR20261937 clinical trial report covering TollB-001, Phase 2, endpoints, sponsor, geography, readout timing and development white space.